PHARMDEKO (PHARMDEKO) is listed on the Nigerian Exchange in the HEALTHCARE sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
HEALTHCARE
₦397M
N/A
N/A
Current price
₦1.83
Updated Updated 13 min ago
Conviction
34/100
Confidence
Low
Market tone
neutral · 50/100
Entry
Low · 34/100
Recent price action for PHARMDEKO, so the page starts with the stock itself before the deeper analysis.
We do not have enough live liquidity data to judge exits properly yet.
Valuation view
Valuation signal is limited
Income view
Income signal not strong yet
Market tone
neutral (50/100) — price action, attention, and recent context all lean here.
Entry view
Low (34/100) — Leverage looks manageable.
PHARMDEKO is a Nigerian healthcare company that develops, manufactures and supplies pharmaceutical preparations and related health products. It makes money by selling those medicines and products to pharmacies, hospitals, distributors and other customers, earning revenue from product sales and distribution.
Investors usually follow PHARMDEKO for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
1
Dividend and company notices.
Market events
0
Insider, filing, dividend, and price events.
Source records
4
Captured updates we can trace.
Whisone is bearish because the bullish case is not yet strong enough to lead while fundamentals are weak at 34/100. Whisone has low conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
-29.3%
Return on equity
Debt / equity
0.03
Lower is usually safer.
P/B ratio
0.39
Useful for book value support.
Execution risk and market swings can still delay the forecast playing out.
Fair value
₦1.82
Forecast refresh
Updated 11h ago
Quality score
44
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 1d ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 2d ago
Bulk intraday company price snapshot from NGXPulse.
Price: ₦101.20
P/E: 21.95
Yield: 1.48%
MAYBAKER
MAYBAKER
Price: ₦40.00
P/E: 15.11
Yield: 0.94%
